Sun Pharma To Buy All Of Israel’s Taro By Upping Offer By 60%
This article was originally published in PharmAsia News
Executive Summary
Sun Pharmaceutical Industries offered more money to buy Taro Pharma, apparently enough to gain the approval by the Israel-based firm’s board, giving the Indian drug manufacturer total control.